To the best of our knowledge, the present study was the first to demonstrate that Nischarin expression levels were significantly lower in patients with lymph node metastasis compared with patients with no lymph node metastasis. This evidence concerns the gene NISCH and metastatic malignant neoplasm in the lymph nodes.